ADC Therapeutics (ADCT) to Cut 17% Workforce, Save $10M Annually

ADC Therapeutics (ADCT) announced it will reduce its workforce by 17%, which will result in annual savings of $10 million. This decision reflects an effort to optimize operational efficiency amid financial challenges. Streamlining the workforce is significant as it may impact the company's cost structure and overall financial health. Investors may view this cost-cutting measure as a strategic response to enhance profitability in a competitive market.